Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-16

Clinical Trial Update: An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients [Phase 4]

View source ↗

Summary

Phase 4 study investigating the effects of olanzapine on sleep architecture and related cognitive changes in patients with bipolar disorder or major depressive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zyprexa (olanzapine)

Snippet

Sponsor: Queen's University | Conditions: Bipolar Disorder, Depression | Phase 4 | Status: COMPLETED